Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.

Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.

SCHAUMBURG, Ill., July 7, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading vertically integrated pharmaceutical company based in China, today announced a strategic collaboration to…

Sagent, Qilu partner to commercialise complex injectable products in US

Through this partnership, Sagent will gain sole rights to commercialise a select portfolio of Qilu’s complex injectable products in the US. These products encompass high-impact therapeutic areas, The post Sagent, Qilu partner to commercialise complex injectable products in US appeared first on Pharmaceutical Business review.